GlassScriptPhysician profile
Mark A Gromski
NPI 1255625679
$154,239.77
in general payments reported to CMS, 2019-2025
13 companies · $42K in 2025
The $42K reported for 2025 was more than what 97% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,344 · 2020: $5,022 · 2021: $16K · 2022: $25K · 2023: $25K · 2024: $40K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $64K · Consulting Fee: $33K · Travel and Lodging: $5,830 · Food and Beverage: $3,527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $64,030.00 |
| Consulting Fee | $32,568.15 |
| Travel and Lodging | $5,830.00 |
| Food and Beverage | $3,527.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $109,463.35 | 2019-2025 | Exalt Model D, General - Therapies, Spyglass |
| Wilson Cook Medical Incorporated | $26,083.82 | 2024-2025 | Fusion, D.A.S.H. |
| Ambu A/S | $12,403.15 | 2023 | |
| Cook Research Incorporated | $3,000.00 | 2024 | |
| Cook Medical LLC | $1,823.55 | 2023-2025 | Fusion, Echotip Insight, D.A.S.H. |
| Ambu INC. | $766.80 | 2021-2024 | |
| Omega Medical Imaging, LLC | $172.51 | 2020-2025 | |
| Olympus America INC. | $148.54 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $131.46 | 2019 | |
| Conmed Corporation | $130.91 | 2025 | Conmed Biliary |
| 3-D Matrix, INC. | $83.88 | 2024 | |
| Olympus Corporation of The Americas | $31.80 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Gromski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.